Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/PBLS/Capital expenditures

Parabilis Medicines, Inc. (PBLS) Capital expenditures

Parabilis Medicines, Inc. (PBLS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to PBLS

Source: SEC XBRL filings · For reference only · Not investment advice

More PBLS financial trends

PBLS RevenuePBLS Net incomePBLS Net marginPBLS Gross profitPBLS Gross marginPBLS Operating incomePBLS Operating marginPBLS Operating cash flowPBLS Free cash flowPBLS Return on equityPBLS Stock buybacksPBLS Dividends paidPBLS Total assetsPBLS Total liabilitiesPBLS Shareholders’ equityPBLS overview →